Atlas Trials

Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes

Clinical trial NCT00609856 · COMPLETED

Trial details

NCT number
NCT00609856
Sponsor
Skane University Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 DiabetesSecondary Drug Failure
Start date
2004-04-01
Primary completion
2006-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.